Motor Unit Abnormalities After Experimentally Induced Sensitization

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

December 20, 2019

Study Completion Date

March 10, 2020

Conditions
Central SensitisationMotor Disorders
Interventions
DRUG

Capsaicin Topical Cream (0.075%)

Capsaicin cream will be administered as a topical skin cream

DEVICE

Delsys Trigno Galileo System

A wireless surface EMG device. The sensors will be placed on the trapezius and the infraspinatus muscle, and a recording will be performed.

DEVICE

Excaliber, Natus Medical

Intramuscular EMG machine. The intramuscular electrode will be inserted into the trapezius and a recording will be performed.

OTHER

Placebo Cream

Placebo cream will be administered as a topical skin cream

Trial Locations (1)

M5S 1A1

Toronto Rehabilitation Institute, Toronto

All Listed Sponsors
lead

Toronto Rehabilitation Institute

OTHER

NCT04361149 - Motor Unit Abnormalities After Experimentally Induced Sensitization | Biotech Hunter | Biotech Hunter